IP Library › Granted Patent US 9,034,927
Granted Patent B2
US 9,034,927 · App. 14/076,149 · Granted May 19, 2015

Methods of use for compositions comprising a biocidal polyamine

Inventors: Dustin Williams (Bountiful, UT); Ryan Looper (Salt Lake City, UT); Sujeevini Jeyapalina (Salt Lake City, UT); Travis Haussener (Midvale, UT); Paul R. Sebahar (Sandy, UT); Hari Kanna Reddy (Salt Lake City, UT)
Assignees: CURZA GLOBAL, LLC; UNIVERSITY OF UTAH RESEARCH FOUNDATION
A01N43/84A61K31/135C07C211/27A01N33/00A01N37/18A01N43/10A01N43/30A01N43/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,034,927
App. No.
14/076,149
Granted
May 19, 2015
Kind
B2
Abstract

Compounds, compositions, and methods comprising a polyamine compound are described, which may be used to kill, disperse, treat, reduce biofilms, and/or inhibit or substantially prevent biofilm formation. In certain aspects, the present invention relates to compounds, compositions, and methods comprising polyamine compounds that have antimicrobial or dispersing activity against a variety of bacterial strains capable of forming biofilms.

Claims (91)

1. A method for dispersing or killing a biofilm, the method comprising a step of contacting the biofilm with an anti-biofilm composition, thereby effectively dispersing or killing the biofilm;

wherein the anti-biofilm composition comprises a biocidal polyamine compound selected from the group consisting of:

and a salt thereof;

wherein:

each R a is a member independently selected from the group consisting of

wherein each A n member is an independently selected CR 5 ;

each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl; or, alternatively, an R 1a and an R 1b join to form an oxo group;

each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; alternatively, a pair of R 2 members from the same R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a member independently selected from the group consisting of spirocycloalkyl, spiroheterocycyl, and oxo; or, alternatively, an R 2a and an R 2c from the same R a group join to form a ring independently selected from the group consisting of cycloalkyl and heterocycyl;

each R m is a member independently selected from the group consisting of —CR 2a R 2b —, —CR 2c R 2d —, —C(R 2a )=(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L 2 -C(R 2c )(R 2d )—;

each m is an integer independently selected from 1 to 20;

each L 1 and L 2 is a member independently selected from the group consisting of a bond, —O—, —C(O)O—, —NR 4 —, —NR 4 C(O)—, and —C(O)NR 4 —;

each R 3 is a member independently selected from the group consisting of —Z 1 —R 4 , Z 1 —Y 1 —R 4 , and Z 1 -Y 1 —Y 2 —Y 3 —R 4 ;

each R 4 is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl; or, alternatively, for a —N(R 4 ) 2 group, one of the two R 4 in the group is a member selected from the group consisting of —(CO)OR 6a —, (CO)N(R 6a )(R 6b ), and —C(NR 6a )N(R 6b )(R 6c );

each R 5 is a member independently selected from the group consisting of hydrogen, alkyl, hydroxyl, alkoxy, alkylamino, alkenyl, alkynyl, aryl, aryloxy, arylamino, cycloalkyl, cycloalkoxy, cycloalkylamino, heterocyclyl, heterocycyloxy, heterocycylamino, halo, haloalkyl, fluoroalkyloxy, heteroaryl, heteroaryloxy, heteroarylamino, arylalkyl, arylalkyloxy, arylalkylamino, heteroarylalkyl, heteroarylalkyloxy, heteroarylalkylamino; hydroxyalkyl, aminoalkyl, and alkylaminoalkyl;

each Y 1 , Y 2 , and Y 3 is an independently selected group of Formula IA:

each Z 1 and Z 2 is a member independently selected from the group consisting of NR 4 and O; and

each R 6a , R 6b , and R 6c is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, cycloalkyl, and heteroarylalkyl; or, alternatively, two R 6n members R 6a and R 6b or R 6a and R 6c form a heterocycyl ring;

wherein the biocidal polyamine compound comprises at least two primary or secondary amino groups.

2. The method of claim 1 , wherein:

each R a is independently a group of Formula II:

each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl;

for each R a member, at most two R m of the R a member are selected from the group consisting of —C(R 2a )=(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L 2 -C(R 2c )(R 2d )—; and

each m is an integer independently selected from 1 to 16.

3. The method of claim 1 ,

wherein:

each R 2a , R 2b , R 2c , R 2d , R 2e , R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; alternatively, a pair of R 2n members from the R a group independently selected from the group R 2a and R 2b , R 2c and R 2d , and R 2e and R 2f join to form a ring independently selected from the group consisting of spirocycloalkyl and spiroheterocycyl; or, alternatively, the R 2a and the R 2c from the R a group join to form a ring independently selected from the group consisting of cycloalkyl and heterocycyl;

each m is an integer independently selected from 1 to 12;

each R 3 is a member independently selected from the group consisting of —Z 1 -Y 1 —R 4 and —Z 1 —Y 1 —Y 2 —R 4 ; and

each Z 1 and Z 2 is an independently selected NR 4 .

4. The method of claim 1 , wherein:

each R 2a , R 2b , R 2c , R 2d , R 2e , and R 2f is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl;

each m is an integer independently selected from 1 to 10;

each L 1 and L 2 is a member independently selected from the group consisting of a bond, —O—, and —NR 4 —;

each R 3 is a member independently selected from the group consisting of —Z 1 —R 4 , —Z 1 —Y 1 —R 4 , and —Z 1 -Y 1 —Y 2 —R 4 ; and

each Z 1 and Z 2 is an independently selected NR 4 .

5. The method of claim 4 ,

wherein:

each R a is independently a group of Formula V:

each R 1a , R 1b , R 1c , and R 1d is a member independently selected from the group consisting of hydrogen, fluoro, alkyl, and fluoroalkyl;

for each R a member, at most two R m of the R a member are selected from the group consisting, of —C(R 2a )=(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L 2 -C(R 2c )(R 2d )—; and

each R 3 is a member independently selected from the group consisting of —Z 1 —Y 1 —R 4 and —Z 1 —Y 1 —Y 2 —R 4 .

6. The method of claim 1 , wherein the biocidal polyamine compound comprises at least four primary or secondary amino groups.

7. The method of claim 1 , wherein the biocidal polyamine compound comprises at least six primary or secondary amino groups.

8. The method of claim 1 , wherein the biocidal polyamine compound is selected from the group consisting of

wherein L 1 is selected from the group consisting of a bond and O; and

wherein R a is an independently selected group of Formula VII:

9. The method of claim 8 , wherein:

R m is —CH 2 —;

each m is 1;

each R 3 is independently —Z 1 —Y 1 —R 4 or —Z—Y 1 —Y 2 —R 4 ;

Z 1 is —NH—;

each Y 1 and Y 2 is independently

 and

R 4 is alkyl.

10. The method of claim 8 , wherein R a is —CH 2 [NH(CH 2 ) n ] p NH 2 ;

wherein each n is an integer independently selected from 3 to 12; and

wherein each p is an integer independently selected from 1 to 3.

11. The method of claim 8 , wherein m is 1;

wherein R m is —CH 2 —; and

wherein R 5 is selected from the group consisting of hydrogen, phenyl, and phenyloxy.

12. The method of claim 8 ,

wherein R 5 is hydrogen;

wherein —Z 1 — is —NH—; and

wherein —Y 1 — is —(CH 2 ) 3 —NH— or —(CH 2 ) 4 —NH—.

13. The method of claim 8 , wherein the biocidal polyamine compound is selected from the group consisting of

and a salt thereof.

14. The method of claim 1 , wherein the biocidal polyamine compound is selected from the group consisting of

and a salt thereof.

15. The method of claim 14 , wherein the biocidal polyamine compound is selected from the group consisting of

and a salt thereof.

16. The method of claim 12 , wherein R a is an independently selected group of Formula VII:

17. The method of claim 14 , wherein R 5 is hydrogen;

wherein L 1 is selected from the group consisting of a bond and O; and

wherein R 4 is alkyl.

18. The method of claim 14 , wherein L 1 is selected from the group consisting of a bond and O.

19. The method of claim 14 , wherein R a is —CH 2 [NH(CH 2 ) n ] p NH 2 ;

wherein each n is an integer independently selected from 3 to 12; and

wherein each p is an integer independently selected from 1 to 3.

20. The method of claim 14 , wherein m is 1; and

wherein R n is —CH 2 —.

21. The method of claim 1 , wherein the polyamine compound is selected from the group consisting of

and a salt thereof.

22. The method of claim 1 , wherein the step of treating the biofilm with an anti-biofilm composition effectively disperses the biofilm.

23. The method of claim 1 , wherein the biofilm comprises an antibiotic-resistant bacterial species.

24. The method of claim 1 , wherein the method comprises a step of treating a contact lens with the anti-biofilm composition.

25. The method of claim 1 , wherein the method comprises a step of treating a pipe with the anti-biofilm composition.

26. The method of claim 1 , wherein the method comprises a step of treating a heating or cooling tower with the anti-biofilm composition.

27. The method of claim 1 , wherein the method comprises a step of coating an object with the anti-biofilm composition.

28. The method of claim 1 , wherein the anti-biofilm composition is a paint.

29. The method of claim 1 , wherein the method comprises a step of treating a patient with a biofilm-related disorder.

30. A method for inhibiting formation of a biofilm, the method comprising a step of treating planktonic bacteria with an anti-biofilm composition of claim 1 , thereby inhibiting incorporation of the planktonic bacteria into the biofilm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2014
From: THE UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 032963/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2013
From: WILLIAMS, DUSTIN; LOOPER, RYAN; JEYAPALINA, SUJEEVINI; HAUSSENER, TRAVIS; SEBAHAR, PAUL R.; REDDY, HARI KANNA
To: CURZA GLOBAL, LLC; THE UNIVERSITY OF UTAH
Reel/Frame 031614/0420 →
Continuity (5)
Provisional Application 61836555 · Jun 18, 2013
Provisional Application 61834149 · Jun 12, 2013
Provisional Application 61826761 · May 23, 2013
Provisional Application 61826453 · May 22, 2013
Related Publication 20140350017A1 · Nov 27, 2014